US to hike fees for generic drugmakers, Indian firms to be hit
August 11, 2013 14:41 ISTNew Delhi, Aug 11: Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by